- 期刊
- OpenAccess
Which ESAs You Will Choose for Dialysis Patients?
參考文獻
Singh AK. ESAs in dialysis patients: Are you a hedgehog or a fox? J Am Soc Nephrol 21: 543-555, 2010.
Caro J, Brown S, Miller O, Murray T, Erslev AJ. Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 93: 449-458, 1979.
Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 321: 158-163, 1989.
Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a combined phase I and II clinical trial. N Engl J Med 316: 73-78, 1987.
Macdougall IC, Padhi D, Jang G. Pharmacology of darbepoetin a. Nephrol Dial Transplant 22 (suppl 4): iv2-iv9, 2007.
延伸閱讀
- 曾柏榮、彭聖曾（2021）。Dialysis Planning for the Elderly: for Whom, and When?。腎臟與透析，33(4)，159-163。https://doi.org/10.6340/KD.202112_33(4).0001
- 張明揚、方基存（2015）。The Clinical Application of Sustained Low-Effifciency Daily Dialysis。腎臟與透析，27(4)，183-186。https://doi.org/10.6340/KD.2015.27(4).05
- 翁玟伶、陳淑萍、鄭昕宜、吳金燕、蔡淑娟、王雅靜、吳徐慧（2021）。Project to Enhance the Willingness of Patients with End-stage Renal Disease to Choose Peritoneal Dialysis。臺灣腎臟護理學會雜誌，20(1)，22-35。https://doi.org/10.3966/172674042021092001003
- 李文欽（2016）。Gastrointestinal Diseases in Dialysis Patients。腎臟與透析，28(4)，185-188。https://doi.org/10.6340/KD.2016.28(4).07
- 馮英鳳、邱小鳳（2012）。Is It Clean?-The Concept of Dialysis Adequacy。臺灣腎臟護理學會雜誌，11(1)，23-25。https://www.airitilibrary.com/Article/Detail?DocID=17267404-201203-201205080012-201205080012-24-26